Gu C, Todorov A, Rao DC Combining extremely concordant sibpairs with extremely discordant sibpairs provides a cost effective way to linkage analysis of quantitative trait loci. Genet Epidemiol. 1996;13(6):513-33.
Li Z, Bonney GE, Lathrop GM, Rao DC Genetic analysis combining path analysis with regressive models: the TAU model of multifactorial transmission. Hum Hered. 1994 Nov-Dec;44(6):305-11.
Li Z, Bonney GE, Rao DC Genetic analysis combining path analysis with regressive models: the BETA path model of polygenic and familial environmental transmission. Genet Epidemiol. 1994;11(5):431-42.
Li Z A multiplicative random effects model for meta-analysis with application to estimation of admixture component. Biometrics. 1995 Sep;51(3):864-73.
Todorov AA, Borecki IB, Rao DC Linkage analysis of complex traits using affected sibpairs: effects of single-locus approximations on estimates of the required sample size. Genet Epidemiol. 1997;14(4):389-401.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
